Sabina Berlin
Fortuna: 55 116 $ al 31/05/2026
Fortuna: 55 116 $ al 31/05/2026
Sabina Berlin is currently Director at Zymology Consulting AB and Chief Financial Officer at Devyser Diagnostics AB since 2021.
Former roles include Chief Executive Officer at Juno Ekonomi AB from 2014 to 2017 and Chief Financial Officer at Irras AB from 2019 to 2021.
Education includes graduate studies at Handelshögskolan i Göteborg.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DEVYSER DIAGNOSTICS AB 0,03 % | 31/12/2024 | 5.472 ( 0,03 % ) | 55 116 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DEVYSER DIAGNOSTICS AB | Director Financiero/CFO | 01/01/2021 |
Zymology Consulting AB | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IRRS ABNPV | Director Financiero/CFO | 17/06/2021 |
Juno Ekonomi AB | Director Ejecutivo | 01/06/2017 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Irras AB
Irras AB BiotechnologyHealth Technology Operates as a commercial-stage medical technology company | Health Technology |
Devyser Diagnostics AB
Devyser Diagnostics AB Medical SpecialtiesHealth Technology Manufactures and sells diagnostic kits | Health Technology |
Zymology Consulting AB | |
Juno Ekonomi AB |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.